Literature DB >> 2298505

Chromosome aberrations in metastatic ovarian cancer: relationship with abnormalities in primary tumors.

M J Bello1, J A Rey.   

Abstract

Twenty malignant effusions secondary to ovarian cancer have been cytogenetically analyzed directly and after short in vitro culture. With the exception of one sample characterized by trisomy 3, all cases displayed clonal structural rearrangements. Chromosomes 1 and 3 were most frequently involved in the genesis of markers. Abnormalities of chromosomes 5, 6, 9, 11 and 12 were also recurrently found, and double minutes (DM) were observed in 2 samples. Our results agree with previous findings on the preferential involvement of chromosomes 1, 3 and 6 in ovarian carcinomas, and suggest that rearrangements of certain chromosomes are non-random but are secondary to the malignant progression of these tumors.

Entities:  

Mesh:

Year:  1990        PMID: 2298505     DOI: 10.1002/ijc.2910450111

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor.

Authors:  D M Panchision; P A Martin-DeLeon; T Takeshima; J M Johnston; K Shimoda; P Tsoulfas; R D McKay; J W Commissiong
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

2.  Regulation of human methylthioadenosine phosphorylase gene by the CBF (CCAAT binding factor)/NF-Y (nuclear factor-Y).

Authors:  Yuwaraj Kadariya; Kaname Nakatani; Junji Nishioka; Takahiko Fujikawa; Warren D Kruger; Tsutomu Nobori
Journal:  Biochem J       Date:  2005-04-01       Impact factor: 3.857

Review 3.  Revisiting characteristics of oncogenic extrachromosomal DNA as mobile enhancers on neuroblastoma and glioma cancers.

Authors:  Mohsen Karami Fath; Nastaran Karimfar; Andarz Fazlollahpour Naghibi; Shahriyar Shafa; Melika Ghasemi Shiran; Mehran Ataei; Hossein Dehghanzadeh; Mohsen Nabi Afjadi; Tahereh Ghadiri; Zahra Payandeh; Vahideh Tarhriz
Journal:  Cancer Cell Int       Date:  2022-05-25       Impact factor: 6.429

4.  Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors.

Authors:  G Chenevix-Trench; J Kerr; M Friedlander; T Hurst; B Sanderson; M Coglan; B Ward; J Leary; S K Khoo
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

Review 5.  The genetic analysis of ovarian cancer.

Authors:  A N Shelling; I E Cooke; T S Ganesan
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

6.  Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.

Authors:  S J C Shan; A Scorilas; D Katsaros; E P Diamandis
Journal:  Br J Cancer       Date:  2007-01-29       Impact factor: 7.640

7.  Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer.

Authors:  W D Foulkes; I G Campbell; G W Stamp; J Trowsdale
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

8.  Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours.

Authors:  H Gabra; L Taylor; B B Cohen; A Lessels; D M Eccles; R C Leonard; J F Smyth; C M Steel
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.